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Myristic acidAbstract The antifungal activity and the chemical constituents of selected macroalgae collected
from the Egyptian Mediterranean coast of Alexandria have been investigated. Agar well diffusion
assay was used to determine the antifungal potential of the extractable matter against Fusarium
solani, Fusarium oxysporum, Tricoderma hamatum, Aspergillus flavipes and Candida albicans. The
ethyl acetate and methanolic extracts (ULE2 and ULM5) of Ulva lactuca obtained from Al Selsela
exhibited the highest activity with (AI) = 1.05 ± 0.053 and 1.03 ± 0.052, respectively, compared
with fluconazole. However, the methanolic extract of U. lactuca (ULM1) from Abu Qir Bay showed
(AI) = 0.73 ± 0.037. This followed by methanolic extracts of Pterocladia capillacea (PCM1:
AI = 0.70 ± 0.035 and Ulva fasciata (UFM1: AI = 0.69 ± 0.035). GC/MS analysis of ULM1
and ULM5 indicated the existence of different constituents revealing ecological impacts. The
methanolic extract (UFM1) contains six major components including palmitic acid, methylester,
trichloromethyloxirane, linolenic acid, ethylester, 3,7,11,15-tetramethyl-2-hexadecen-1-ol,
11-octadecenoic acid, methylester and 12,15-octadecadienoic acid, methylester. High percentages
of palmitic acid, n-heptacosane, 2-methylhexadecan-1-ol, methoxy acetic acid, 2-tridecylester and
myristic acid are found in the methanolic extract of P. capillacea (PCM1). Most of the identified
components have been reported to possess antimicrobial activity that could be responsible for
the antifungal potential reported in the present study.
 2016 National Institute of Oceanography and Fisheries. Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Marine environment is a good source of bioactive natural
products exhibiting structural/chemical features that are not
found in terrestrial natural compounds (Carter, 1996). Several
marine organisms produce bioactive metabolites in response to
290 A.H. Shobier et al.ecological pressures (Ireland et al., 2000). They develop a
chemical strategy for defense against other organisms in their
environment and to ensure their survival (Ko¨nig et al.,
1994). Numerous novel compounds have been isolated from
marine organisms (Jha and Zi-rong, 2004; Arunkumar et al.,
2010; D’Orazio et al., 2012; Mayer et al., 2013; Balakrishnan
et al., 2014; Pal et al., 2014). Blunt et al. (2016) reported that
approximately 25 700 new marine natural products (MNPs)
have been discovered over the period 1965–2014 from 22 ocea-
nic regions or countries. There have been extensive collections
with 2358 compounds in the Mediterranean, Arabian Penin-
sula and Black sea regions. This high diversity has been the
source of unique natural compounds used for various indus-
trial developments such as pharmaceuticals, cosmetics and
nutritional supplements (Suleria et al., 2015). Marine macroal-
gae have been widely recognized as producers of a broad range
of biogenic compounds including polyunsaturated fatty acids,
flavonoids, terpenoids, alkaloids, quinones, sterols, polyke-
tides, phlorotannins, polysaccharide, glycerols, peptides and
lipids (Al-Saif et al., 2014; El-Din and El-Ahwany, 2015) that
have antimicrobial (Zbakh et al., 2012), antifouling (Bhadury
and Wright, 2004), anti-inflammatory (Jaswir and Monsur,
2011), antiviral (Bouhlal et al., 2011), antioxidant (Devi
et al., 2011), anticancer (Kim et al., 2011), anti-allergic (Na
et al., 2005) and anticoagulant activities (Dayong et al.,
2008; Kolanjinathan et al., 2014; Smit, 2004). For example,
the green alga Enteromorpha compressa is rich in C18
PUFAs ± a-linolenic (18:3n-3) and octadecatetraenoic
(18:4n-3) acids where a-linolenic acid is the main polyunsatu-
rated acid (Khotimchenko et al., 2002) and the flavonoids con-
tent is 33.39 mg/g as reported by Sarojini et al. (2012).
In recent years, a significant number of reviews reported
numerous investigations that have been carried on crude and
purified compounds obtained from marine algae to evaluate
their bioactive potentials (Mhadhebi et al., 2012;
Balamurugan et al., 2013; Barbosa et al., 2014; Torres et al.,
2014; Kolanjinathan et al., 2014; El-Din and El-Ahwany,
2015; Hamed et al., 2015; Blunt et al., 2016). The first antimi-
crobial substances produced by algae have been reported by
Harder (1917). The variation in the production of antimicro-
bial substances by the same species might be due to ecology,
sexual maturity or the stage of active growth (Pesando, 1990;
Burkholder et al., 1960). The extracts of an alga collected from
the same location are more effective than the same species col-
lected from another location as reported by Arunkumar et al.
(2010). Lee et al. (2010) studied the antifungal activity of Eck-
lonia cava brown algae against Trichophyton rubrum. A study
on the antifungal activities of five species of Laurencia red
algae against three strains of Candida spp. was carried out
(Stein et al., 2011). Crude extracts of green, brown and red
algae have been screened for the antifungal potential against
standard dermatophytes strains (Guedes et al., 2012).
Recently, screening of the antifungal activity from marine
algae as prominent natural antibiotic was presented by
Chowdhury et al. (2015) where new terpenoid derivatives from
the red alga Laurencia obtusa considered as effective
antifungal-antitumor agents (Alarif et al., 2015). Different
analysis methods such as GC/MS, LC/MS, HPLC/DAD and
CE/DAD (diode array detection) have been developed for
the identification of the bioactive constituents (Gong et al.,
2001). Mass selective detector spectral information in additionto retention time, peak height and peak area information
enhances the identification of the components.
Several studies have been reported on the antibacterial
activity of marine algae however, available information on
their antifungal activity is limited. Consequently, the present
investigation aimed to evaluate the antifungal activity of six
Mediterranean macroalgae extracts, collected from the coast-
line of Alexandria, against five pathogenic fungi in order to
discover potential antifungal metabolites. Qualitative identifi-
cation of the most potential antifungal extracts of Ulva lactuca,
Ulva fasciata and Pterocladia capillacea was performed using
retention times and mass spectra in the GC/MS analysis.
Materials and methods
Samples collection
Six fresh seaweeds; U. lactuca, U. fasciata, E. compressa,
P. capillacea, Hypnea musciformis and Padina pavonica were
harvested at various sites along the Mediterranean Egyptian
coast of Alexandria (Abu Qir Bay, Al Selsela and
El-Anfoushy). After collection, the samples were rinsed with
fresh water to remove associated epiphytes and debris. The
cleaned algal materials were then air dried to dryness in the
shade and ground into fine powder using electric grinder mixer.
Preparation of the algal extracts
Extraction of the bioactive algal extracts has been carried out
using ethyl acetate and methanol as follows; the finely pow-
dered algal material (100 g) was macerated separately in ethyl
acetate (1.5 L) followed by methanol (1.5 L) at room tempera-
ture for a period of one week with regular shaking. After filtra-
tion, organic solvents were evaporated under vacuum at 45 C
to furnish dry ethyl acetate and methanolic extracts. The
extraction procedure with each solvent was repeated once
again to furnish ethyl acetate extracts as green residues while
methanolic extracts were separated as green residues (ULM1,
ULM5, UFM1, ECM, PCM1, HM1, and PPM1) or white pre-
cipitates (ULM3, ULM4), crystals (ULM7) or pale yellow liq-
uids (ULM2, ULM6, UFM2, PCM2, HM2, PPM2). The
crude extractable materials were then stored at -20 C until
use (Choudhury et al., 2005; Wefky et al., 2009; Shobier
et al., 2010).
Test organisms
The test organisms used in this study (Fusarium solani AUMC
6448, Fusarium oxysporum AUMC 6449, Tricoderma hamatum
AUMC 382, Aspergillus flavipes AUMC 6450 and Candida
albicans ATCC 10231) were kindly provided by Assiut Univer-
sity Mycological Center, Faculty of Science. These fungal
strains were subcultured onto potato-dextrose agar (PDA)
supplemented with Rose Bengal for 5–7 days at 28–33 C.
Antifungal assay
The in vitro antifungal analysis of the studied algal extracts
was recorded in terms of a well cut technique (Bodet et al.,
1985). Fungal colonies were diluted in sterilized water to 0.5
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sion). Individually, each dermatophyte and Candida species
were inoculated through swabbing on plates containing solid
PDA. Four wells with 5 mm in diameter were punched for
100 ll of algal extracts (without dilution for liquid samples
and at a concentration of 1 mg/ml for others). Afterward,
plates were incubated at 28 C for 7 days with dermatophytes
and 33 C for 48 h with Candida species and the results were
determined from the presence or absence of growth and size
of the inhibition zone.
Activity index
The activity index (AI) was used to compare the antimicrobial
activity of the algal extracts against all fungal strains with that
of the standard drug at the tested concentrations. It was calcu-
lated using the following equation (Egharevba et al., 2010)
AI¼ Mean of the extract inhibition zone diameter
Mean of the standard antibiotic drug inhibition zone diameterMicrodilution assay
Microdilution assay was performed according to CLSI
documentM38-A2 (2002). The suspensions of each fungus were
prepared with 5 ml of sterile distilled water. The suspensions
were then diluted (1:50) in order to obtain the final inoculum
concentration of 5  104 spores/ml. Potent algal extracts
(100 ll) with different concentrations from 1 to 265 lg ml1
were added in test tubes containing 3 ml potato-dextrose broth
(PDB). Equal volume of cell suspensions (100 ll) was inocu-
lated and incubated without agitation, for result interpretation.
Control was included for each test, containing medium with
100 ll of antibiotics (positive control) and medium with 100 ll
spores (negative control). The antifungal activities of the potent
algal extracts were compared with reagent-grade powder antibi-
otics; miconazole, fluconazole and itraconazole at 100 lg ml1
while dimethyl sulfoxide (DMSO) was used as negative control.
Each assay was carried out in duplicate and the minimum inhi-
bitory concentration (MIC) of algal extracts was determined by
visual inspection of each tube through the evaluation of the fun-
gal growth inhibition using growth as control.MICs were deter-
mined by choosing the lowest concentration of the algal extract
preventing fungal spores (da Silva Barros et al., 2007).
Gas chromatography/Mass spectrometry (GC/MS) analysis
GC/MS analysis was carried out using Gas Hewlett Packard
HP-5890 series II equipped with split/splitless injector and a
capillary column (30 m, 0.25 mm, 0.25 lm) fused with phenyl
polysilphenylene siloxane. The injector and detector tempera-
tures were set at 280 and 300 C, respectively, and the oven
temperature was kept at 80 C for 1 min, rose to 300 C at
20 C/min. Helium was used as carrier gas at a constant flow
of 1.0 ml/min. A volume of 2 ll was injected in the splitless
mode and the purge time was 1 min. The MS (Hewlett–Pack-
ard 5889B MS Engine) with selected ion monitoring (SIM)
was used. The mass spectrometer was operated at 70 eV and
scan fragments from 50 to 650 m/z. Peak identification of
crude algal extracts was performed based on comparing the
obtained mass spectra with those available in NIST library.Statistical analysis
Origin Lab 6 was used to find out the significant difference at
5% level and analyze the activity indices of each algal extract.
Results and discussion
Antifungal potential
In the present work, different extractable materials from mar-
ine algae collected from the Egyptian Mediterranean coastline
of Alexandria have the ability to produce bioactive compounds
with potential therapeutic interest. The methods used to eval-
uate the antifungal activity were agar diffusion and MIC tech-
niques due to their low cost and simple implementation
(Ibtissam et al., 2009). The combination of different methods
provides a significant platform to discover new antifungal
drugs for dermatophytosis and mycosis disease treatment
(Peres et al., 2010).
The highest antifungal activities against all tested fungi
were exerted by both ethyl acetate (ULE2) and methanolic
(ULM5) extracts of U. lactuca, collected from Al Selsela, with
IZ ranging from 18 to 32 mm, average zone of inhibition 23.2
and 22.6 mm and activity index (AI = 1.05 ± 0.053 and 1.03
± 0.052, respectively) (Table 1, Figs. 1 and 2). However, the
methanolic extract of U. lactuca (ULM1) obtained from Abu
Qir Bay exhibited an (AI) value at 0.73 ± 0.037. The methano-
lic extracts of U. fasciata (UFM1) and P. capillacea (PCM1)
showed an average antifungal activity (AVG) of 15.2 and
15.4 mm; (AI) = 0.69 ± 0.035 and 0.70 ± 0.035, respectively.
Lower antifungal activities were detected by the remaining
extracts that possessed AI values between 0.24 ± 0.012 and
0.55 ± 0.035 except PPM1 in which, the minimum of three
fungal strains must be susceptible to achieve higher antifungal
activities for comparison (Fig. 2). Similarly, the antifungal
activity of different green algal species studied by Abedin
and Taha (2008) against Aspergillus niger and Aspergillus
flavus ranged from 20 to 35 mm. Ertu¨rk and Tas (2011)
mentioned that Ulva rigida extracts showed activity against
A. niger and C. albicans at 12 mm. Chloroform and ethyl
acetate extracts obtained from marine brown algae showed
antifungal effect against C. albicans that ranged from 9 to
25 mm as reported by Mhadhebi et al. (2012). However, no
activity was observed using different U. lactuca extractable sol-
vents (Guedes et al., 2012). Nine organic fractions of hexane,
ethyl acetate and methanolic extracts from the red alga
Bostrychia tenella have been reported to display strong fungal
growth inhibition in Cladosporium sp. as an evaluated strain
(de Felı´cio et al., 2010).
Since microdilution method is the best technique mainly,
due to the sensitivity and minimal amount of reagents, thus
applying 2 lg ml1 of U. lactuca extract (ULE2) exhibited
the maximum activity against T. hamatum compared with flu-
conazole and itraconazol which had activities at 4 lg ml1 and
8 lg ml1, respectively. This was followed by the effect of
U. lactuca methanolic extract (ULM5) against A. flavipes
and F. oxysporum with MIC = 4 lg ml1. Almost all fungal
strains were susceptible to U. lactuca methanolic extract
(ULM1) by 8 lg ml1 where both fluconazole and itraconazol
have the same effect. Higher MIC values were detected using
U. fasciata extract (UFM1) since 128 lg ml1 was enough to
Table 1 Diameter of the inhibition zones (mm) of crude extracts against different fungal species.
Species Extract Sample
Code
Inhibition zone diameter (mm)
F. solani
AUMC 6448
F. oxysporum
AUMC 6449
T. hamatum
AUMC 382
A. flavipes
AUMC 6450
C. albicans
ATCC 10231
AVG
U. lactuca
(Abu Qir Bay)
Ethyl
acetate
ULE1 0 10 15 15 12 10.4
Methanol ULM1 12 23 23 22 0 16
ULM2 11 15 0 0 0 5.2
ULM3 0 12 0 10 11 6.6
ULM4 0 20 0 15 10 9
U. lactuca
(Al Selsela)
Ethyl
acetate
ULE2 18 18 25 32 23 23.2
Methanol ULM5 18 25 25 25 20 22.6
ULM6 13 0 15 15 0 8.6
ULM7 0 0 10 13 12 7
U. fasciata
(El-Anfoushy)
Ethyl
acetate
UFE 0 0 0 15 15 6
Methanol UFM1 18 18 10 20 10 15.2
UFM2 13 15 12 0 0 8
E. compressa
(Abu Qir Bay)
Methanol ECM 15 0 0 22 13 10
P. capillacea
(Abu Qir Bay)
Methanol PCM1 15 15 15 15 17 15.4
PCM2 10 15 0 0 15 8
H. musciformis
(Abu Qir Bay)
Methanol HM1 12 15 14 0 12 10.6
HM2 10 0 13 25 12 12
P. pavonica
(Abu Qir Bay)
Methanol PPM1 10 18 25 10 14 15.4
PPM2 10 0 10 0 12 6.4
Miconazole (MCZ) 20 20 20 25 19 20.8
Fluconazole (FLC) 22 20 23 25 20 22
Itraconazole (ITC) 20 22 20 22 21 21
AVG: average of inhibition zone.
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vious study by Ertu¨rk and Tas (2011) indicated that the anti-
fungal activity of U. rigida extracts against A. niger and C.
albicans was at MIC more than 10 lg ml1. Screening for the
antifungal activities of Brazilian seaweed extracts against C.
albicans (ATCC 10231) showed a range of 65–303 lg ml1
(Stein et al., 2011). Dichloromethane and ethanol extracts
fromH. musciformis had MIC at 8 lg ml1 against C. albicans.
Padina gymnospora chloroform extract demonstrated MIC at
16 lg ml1 against Candida parapsilosis and Candida krusei
(Guedes et al., 2012). Guedes et al. (2012) reported that U. lac-
tuca aqueous extract exhibited MIC at 5 lg ml1 against T.
rubrum and Epidermophyton floccosum. The antifungal poten-
tial from the marine red alga B. tenella showed MIC values
ranging from 16 to 19 lg ml1 (de Felı´cio et al., 2010).
GC/MS analysis of the most effective extracts
Many species of macroalgae contain useful constituents such
as myristic acid, palmitic acid, stearic acid (Agoramoorthy
et al., 2007; Balamurugan et al., 2013), phenols, indoles, aceto-
genins, terpenes, labdane diterpenes, brominated hydro-
quinones, tropodithietic acid and phlorotannins (Iban˜ez
et al., 2012; Samarakoon and Jeon, 2012) which may produce
antibiosis against fungi which cause the antimicrobial activityof algae. Bergasson et al. (2011) reported that lipids block
microbes by distracting the cellular membrane of bacteria,
fungi and yeasts. Balamurugan et al. (2013) isolated
n-hexadecanoic acid, tetradecanoic acid, oleic acid,
9-octadecenoic acid, 6-octadecenoic acid, hexadecanoic acid,
ethyl ester, ethyl tridecanoate and octadecanoic acid from
the ethanolic extract of H. musciformis. Usha and Maria
Victorial Rani (2015) identified several compounds in the
methanolic extract of P. pavonica including myristic acid, pal-
mitic acid, linoleic acid, myristic acid ester, palmitic acid ester
and oleic acid ester. Terpenes and sterols are present in high
amount in this alga where 3-furoic acid and phytol are the
main components of terpenes (El Shoubaky and Salem,
2014-2015).
In the present investigation, the CG/MS analysis of
U. lactuca, U. fasciata and P. capillacea crude extracts;
ULE2, ULM1, ULM5, UFM1 and PCM1 showed a mixture
of various components. The total number of the main peaks
observed for U. lactuca collected from Al Selsela was 11 peaks
for ethyl acetate (ULE2) and 14 peaks for methanolic (ULM5)
extracts (Figs. 3 and 4). However, the methanolic extract of
U. lactuca obtained from Abu Qir Bay (ULM1) exhibited 13
peaks (Fig. 5). The methanolic extract of U. fasciata harvested
from El-Anfoushy (UFM1) possessed 17 peaks (Fig. 6) while,
P. capillacea methanolic extract (PCM1) collected from Abu
(E)
(A)
(D)
(B) (C)
ULM5
ULE2
UFM1
PCM1
ULE2
ULM5
PCM1ULM1
ULE2
ULM5 ULM1
PCM1
ULM5
UFM1
ULM1
PCM1 ULM5
PCM1
UFM1ULM1
Figure 1 Antifungal activity of U. lactuca, U. fasciata and P. capillacea extracts (ULM1, ULE2, ULM5, UFM1 and PCM1) against A.
flavipes (A), F. solani (B), F. oxysporum (C), T. hamatum (D) and C. albicans (E).
Figure 2 Activity indices of crude algal extracts against test fungal strains. Bars are expressed as mean ± SE; n= 5 (Origin Lab. 6).
GC/MS spectroscopic approach and antifungal potential 293Qir Bay gave rise to 15 peaks (Fig. 7). The components were
identified and compared with previously isolated compounds.
Most of these components have been found to possess antimi-
crobial, antioxidant, antiinflammatory, antitumor and anti-
cancer activities (Smit, 2004; Mayer and Hamann, 2004;
Mayer and Lehmann, 2001; Flora and Maria Victorial Rani,
2013; El Shoubaky and Salem, 2014-2015; Usha and MariaVictorial Rani, 2015). Results indicated that seven phytocom-
pounds were characterized and identified in the U. lactuca
ethyl acetate extract (ULE2) as shown in Table 3. The main
chemical constituents found in high percentages are dichloroa-
cetic acid, heptadecyl ester (retention time RT= 7.91 min) fol-
lowed by (9Z)-9,17-octadecadienal (RT = 8.79 min), methyl
14-methylheptadecanoate (RT = 9.55 min), and di-n-
Table 2 Minimum inhibitory concentration (MIC) of crude algal extracts against test fungal strains compared with standard
antibiotics used as antifungal drugs.
Algal extracts MIC (lg/ml)
A. flavipes AUMC
6450
F. solani AUMC
6448
F. oxysporum AUMC
6449
T. hamatum AUMC
382
C. albicans ATCC
10231
U. lactuca (ULE2) 4 16 16 2 8
U. lactuca
(ULM1)
8 64 8 8 16
P. capillacea
(PCM1)
32 32 16 32 16
U. fasciata
(UFM1)
128 16 16 16 128
U. lactuca
(ULM5)
4 16 4 4 16
Miconazole 16 16 16 4 16
Fluconazole 8 8 16 4 16
Itraconazole 16 16 8 8 8
Figure 3 GC/MS chromatogram of U. lactuca ethyl acetate extract (ULE2) collected from Al Selsela.
Figure 4 GC/MS chromatogram of U. lactuca methanolic extract (ULM5) collected from Al Selsela.
294 A.H. Shobier et al.octylphthalate (RT = 12.85 min). For methanolic extract
(ULM5) of the same alga, eleven components were identified
and the most abundance five constituents were 1-
heptadecanol (RT = 7.91 min) followed by palmitic acid,
ethylester (RT = 9.86 min), oleic acid (RT = 9.55 min), 3,7,1
1,15-tetramethyl-2-hexadecen-1-ol (RT = 9.05 min) and 3-
icosyne (RT = 8.78 min) (Table 4). However, GC/MS analysis
of the methanolic extract of U. lactuca (ULM1) revealed thatnine components were identified with retention times as pre-
sented in Table 5. The main identified constituents found in
high amounts are phthalic acid, isodecyloctylester
(RT = 12.85 min), myristyl chloride (RT = 7.94 min) and tri-
chloroethylene (RT = 5.69 min). Previous phytochemical
investigation on U. lactuca, collected from the Alexandria
coast, led to the isolation of (E)-6-octadecen-5-ol and (E)-6-
heptacosen-5-one as new compounds along with palmitic acid,
Figure 5 GC/MS chromatogram of U. lactuca methanolic extract (ULM1) collected from Abu Qir Bay.
Figure 6 GC/MS chromatogram of U. fasciata methanolic extract (UFM1) collected from El-Anfoushy.
Figure 7 GC/MS chromatogram of P. capillacea methanolic extract (PCM1) collected from Abu Qir Bay.
GC/MS spectroscopic approach and antifungal potential 295docosanoic acid, (Z)-10-hexacosene and isofucosterol (El
Ashry et al., 2011). Another study by Abbassy et al. (2014)
found that U. lactuca methanolic extract contains 42 compo-
nents and the main five components were 1,2-benzene dicar-
boxylic acid, bis(2-ethylhexyl) ester, palmitic acid,
benzene,1,2,4-trimethyl, 8-octadecanoic acid methyl ester and
benzene,1-ethyl-2-methyl.
The methanolic extract of U. fasciata (UFM1) was found to
contain palmitic acid, methylester (RT = 9.55 min) as the
most abundant compound followed by trichloromethyloxirane
(RT = 5.70 min), linolenic acid, ethylester (RT = 10.66 min),
3,7,11,15-tetramethyl-2-hexadecen-1-ol (RT = 9.04 min), 11-
octadecenoic acid, methylester (RT = 10.53 min) and 12,15-octadecadienoic acid, methylester (RT = 8.77 min) (Table 6).
Abou-El-Wafa et al. (2009) found that the dichloromethane
extract of the alga furnished the new fatty acids; (E)-11-oxo-
octadeca-12-enoic acid, 6-hydroxy-oct-7-enoic acid and (E)-
11-hydroxy-octadeca-12-enoic acid besides cholesterol while
the non polar part of the extract produced ten compounds;
4-oxo-pentanoic acid, hexadecanoic acid, dimethylsulfoxide,
dimethylsulfone, phenylacetamide, 6,10,14-trimethyl-pentade
can-2-one, 8-heptadecene, dodecane, tridecane, and the new
compound 1,1-bicyclohexyl. Sivakumar et al. (2014) reported
that crude ethyl acetate extract contains bis (2-ethylhexyl)
phthalate and 1,2-benzenedicarboxylic acid- butyl as main
chemical constituents. The crude extract of U. fasciata has
Table 3 Chemical constituents of U. lactuca ethyl acetate extract (ULE2) collected from Al Selsela.
Peak No. RT (min) Component name Molecular formula MW (m/z) Hit SI RSI Prob.
1 7.91 Dichloroacetic acid, heptadecyl ester C19H36Cl2O2 366 3 737 739 5.39
2 8.28 Unidentified – – – – – –
3 8.79 (9Z)-9,17-Octadecadienal C18H32O 264 4 719 756 4.03
4 9.04 Unidentified – – – – – –
5 9.55 Methyl 14-methylheptadecanoate C17H34O2 270 1 664 667 14.43
6 9.90 Unidentified – – – – – –
7 10.81 Ethyl oleate C20H38O2 310 4 719 757 6.69
8 10.92 Oleic acid C18H34O2 282 1 722 754 14.76
9 11.49 Tributyl acetylcitrate C20H34O8 402 2 607 672 42.36
10 11.67 Unidentified – – – – – –
11 12.85 Di-n-octylphthalate C24H38O4 390 1 633 667 11.17
SI = Direct match value; RSI = Reverse match value; Prob. = Probability value.
Table 4 Chemical constituents of U. lactuca methanolic extract (ULM5) collected from Al Selsela.
Peak No. RT (min) Component name Molecular formula MW (m/z) Hit SI RSI Prob.
1 5.70 o-Chlorofluorobenzene C6H4ClF 130 2 618 631 12.53
2 6.15 Unidentified – – – – – –
3 6.70 Decylether C20H42O 289 1 712 746 12.55
4 7.91 1-Heptadecanol C17H36O 256 4 695 716 4.26
5 8.78 3-Icosyne C20H38 278 2 700 716 4.15
6 8.94 Unidentified – – – – – –
7 9.05 3,7,11,15-Tetramethyl-2-hexadecen-1-ol C20H40O 296 1 718 786 14.36
8 9.55 Oleic acid C18H34O2 282 5 717 731 4.22
9 9.86 Palmitic acid, ethylester C18H36O2 284 4 610 702 73.52
10 9.90 Unidentified – – – – – –
11 10.54 10-Octadecenoic acid, methylester C19H36O2 296 1 771 777 7.83
12 10.82 Ethyl oleate C20H38O2 310 2 715 734 6.68
13 12.29 Nonadecanoic acid, methylester C20H40O2 312 3 614 657 7.09
14 12.55 Tridecanoic acid,13-formyl-ethylester C16H30O3 270 5 588 651 2.37
SI = Direct match value; RSI = Reverse match value; Prob. = Probability value.
Table 5 Chemical constituents of U. lactuca methanolic extract (ULM1) collected from Abu Qir Bay.
Peak No. RT (min) Component name Molecular formula MW (m/z) Hit SI RSI Prob.
1 5.69 Trichloroethylene C2HCl 130 2 558 609 8.54
2 6.04 n-Nonadecane C19H40 268 3 716 786 4.16
3 6.71 7-Methylpentadecane C16H34 226 4 692 725 4.48
4 7.34 n-Octadecyl chloride C18H37Cl 288 3 663 668 6.63
5 7.83 Hexa-hydro-farnesol C15H32O 228 1 690 704 12.70
6 7.94 Myristyl chloride C14H29Cl 232 1 663 682 9.74
7 8.41 Unidentified – – – – – –
8 9.05 Unidentified – – – – – –
9 9.57 Unidentified – – – – – –
10 9.91 Unidentified – – – – – –
11 10.05 6-Methyloctadecane C19H40 268 4 666 737 6.66
12 10.52 5-Octadecenal C18H34O 266 3 714 728 13.09
13 12.85 Phthalic acid, isodecyloctylester C26H42O4 418 5 702 740 2.70
SI = Direct match value; RSI = Reverse match value; Prob. = Probability value.
296 A.H. Shobier et al.been found to contain twenty-eight compounds. The identified
compounds include 4-hexahydroxy flavoneacetyl B glucopyra-
noside, formycin-A, adenosine, 50-deoxyguanosine and
n-alkenylhydroquinol dimethyl ether (Abdel-Khaliq et al.,2014). a-Linolenic acid, stearidonic acid, ulvanobiuronic
acid 3-sulfate, bromophenolic, sphingosine-type compound
and guaiane sesquiterpene derivatives (guai-2-en-10a-ol and
guai-2-en-10a-methanol) have been previously isolated from
Table 6 Chemical constituents of methanolic U. fasciata extract (UFM1) collected from El-Anfoushy.
Peak No. RT (min) Component name Molecular formula MW (m/z) Hit SI RSI Prob.
1 4.40 Unidentified – – – – – –
2 5.70 Trichloromethyloxirane C3H3Cl3O 160 5 537 538 7.12
3 6.70 3,3,5-Trimethylhexahydroazepine C9H19N 141 4 648 710 4.39
4 7.33 2-Butyl-1-octanol C12H26O 186 4 682 741 5.97
5 7.92 Unidentified – – – – – –
6 8.52 Unidentified – – – – – –
7 8.77 12,15-Octadecadienoic acid, methylester C19H34O2 294 4 683 703 4.73
8 9.04 3,7,11,15-Tetramethyl-2-hexadecen-1-ol C20H40O 296 2 721 800 9.02
9 9.55 Palmitic acid, methylester C17H34O2 270 1 681 688 38.82
10 9.90 Unidentified – – – – – –
11 10.47 Phytol C20H40O 296 2 718 750 9.79
12 10.53 11-Octadecenoic acid, methylester C19H36O2 296 2 752 760 6.34
13 10.66 Linolenic acid, ethylester C20H34O2 306 5 706 711 6.63
14 10.90 2-cis-9-Octadecenyloxylethanol C20H40O2 312 1 720 737 32.73
15 11.41 E,E,Z-1,3,12-Nonadecatriene-5,14-diol C19H34O2 294 5 680 737 3.90
16 12.29 Docosanoic acid, methylester C23H46O2 354 3 614 639 10.55
17 12.84 Unidentified – – – – – –
SI = Direct match value; RSI = Reverse match value; Prob. = Probability value.
Table 7 Chemical constituents of P. capillacea methanolic extract (PCM1) collected from Abu Qir Bay.
Peak No. RT (min) Component name Molecular formula MW (m/z) Hit SI RSI Prob.
1 4.40 Bicyclo[2.2.1]heptane-2,3-dithiol C7H2S2 160 1 576 579 13.20
2 5.70 Unidentified – – – – – –
3 6.05 2,5,6-Trimethyldecane C13H28 184 4 723 865 3.51
4 6.71 2-Ethyl-1-decanol C12H26O 186 2 705 754 6.43
5 7.34 Methoxy acetic acid, 2-tridecylester C16H32O3 272 1 697 742 10.91
6 7.92 n-Heptacosane C27H56 380 2 713 774 7.33
7 8.50 2-Methylhexadecan-1-ol C17H36O 256 1 693 697 11.03
8 8.85 Myristic acid C14H28O2 228 4 618 648 10.65
9 9.04 Unidentified – – – – – –
10 9.55 Unidentified – – – – – –
11 9.92 n-hexadecanoic acid C16H32O2 256 1 683 683 40.49
12 10.04 Estra-1,3,5(10)trien-17b-ol C18H24O 256 4 663 707 5.21
13 10.53 4-Octadecenal C18H34O 266 3 687 718 8.05
14 10.88 Unidentified – – – – – –
15 12.85 Di-n-octylphthalate C24H38O4 390 3 542 588 7.35
SI = Direct match value; RSI = Reverse match value; Prob. = Probability value.
GC/MS spectroscopic approach and antifungal potential 297U. fasciata (Chakraborty et al., 2010; Paulert et al., 2009). The
data recorded for methanolic extract of the red alga P. capil-
lacea (PCM1) showed that of the eleven compounds identified;
the most prevailing compounds were palmitic acid (n-
hexadecanoic acid, RT = 9.92 min), n-heptacosane
(RT = 7.92 min), 2-methylhexadecan-1-ol (RT = 8.50 min),
methoxy acetic acid, 2-tridecylester (RT = 7.34 min), and
myristic acid (RT = 8.85 min) as shown in Table 7. Wefky
and Ghobrial (2008) reported that the ethanol extract of the
alga afforded hexadecanoic acid, 1,3,6,9b-tetra-azaphenalene-
4-cabonitrile,7,9-dibromo-2-(dibromomethyl), 1,3,5,7,9,11-hex
avinyl-3,5,9,11, Tris (trimethylsilyl)-8,20-thioanhyroadenosine,
corydaline, 1,3-dimethyl-4-azaphenanthrene, and
1,1,1,3,5,5,5-heptamethyl trisiloxane. However, the acetone
extract furnished three compounds only; heptadecane, 4-
hydroxy-4-methyl-2-pentanone and 2,3-dimethyl-5-hexan-3-
ol. El-Din and El-Ahwany (2015) mentioned that the crudeextracts of P. capillacea contain n-hexadecanoic acid, choles-
terol, heneicosane, tetradecanoic acid, trans-13-octadecenoic
acid, cis-5,8,11,14,17-eicosapentaenoic acid methyl ester and
1,2-benzenedicarboxylic acid.Conclusions
Comparison of the chemical composition of the green, red and
brown macroalgae collected from various areas of the Egyp-
tian Mediterranean coast of Alexandria showed that, the tax-
onomic differences and the environment play an important
role in the variability of the bioactivity and the chemical con-
stituents. It is important to consider that the algal extracts are
unpurified and contain both polar and non polar compounds
that could be responsible for the antifungal properties reported
here. The unidentified compounds cannot be matched with any
298 A.H. Shobier et al.compounds recorded in the library data base. Egyptian marine
macroalgae have the ability to produce bioactive compounds
of antifungal potential.Conflict of interest
There is no conflict of interest.
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